Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.
Year | ID | Type | Category | Title | Authors |
---|
2023 | NPP01 | Poster | Neuropathology and pathogenesis |
Cerebrospinal Fluid Eosinophils in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) |
Alexandra B Kornbluh, MD1, Victor M Campano, BS, MS2, Pallavi Dwivedi, MS, MPH3, William Suslovic, BS4 and Ilana Kahn, MD1, (1)Neurology, Children’s National Hospital, Washington, DC, (2)The George Washington University School of Medicine and Health Sciences, Washington, DC, (3)Biostatistics, Children’s National Hospital, Washington, DC, (4)Children’s Research Institute, Children’s National Hospital, Washington, DC |
2023 | NPP02 | Poster | Neuropathology and pathogenesis |
Profiling Omega Fatty Acid Derived Lipid Mediators in Relapsing-Remitting Multiple Sclerosis Patients |
Mirela Cerghet, MD, PhD1,2, Insha Zahoor, PhD3, Jeffrey Waters, BS3, Indrani Datta, MS4, Laila Poisson, PhD4, Ramandeep Rattan, PhD5 and Shailendra Giri, PhD6, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI, (3)Neurology, Henry Ford Health System, DETROIT, MI, (4)Public Health Sciences, Henry Ford Health System, Detroit, MI, (5)Gynaecology Oncology, Henry Ford Health System, Detroit, MI, (6)Neurology, Henry Ford Health System, Detroit, MI |
2023 | PGM01 | Poster | Programs |
National MS Society Monthly New to MS: Navigating Your Journey Educational and Engagement Program |
Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Anzada, P., Bennett, D., Benson, T., Carlson, W., Farsaci, N., Henderson, L, Lerdahl, M., Liserio, E., MacIsaac, S., Mazzella, S., Tauchman, J., Vohs, L., Smoczynski, J. |
2023 | PGM02 | Poster | Programs |
Can Do Multiple Sclerosis Black Community Take Charge® Program: A 1 ½ Day Program Focused on Learning, Connection and Activation |
Laura Allen, Director of Programs1, Abbey J. Hughes, PhD2, Rosalind Kalb, PhD1 and Kathleen Costello, MS, CRNP, MSCN1, (1)Programs, Can Do Multiple Sclerosis, Avon, CO, (2)Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD |
2023 | PGM03 | Poster | Programs |
The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence |
Paul Hanusch, RN, BSN, MHA1, Kian Jalaleddini, PhD1, Danielle Siniscalchi, MBA1, Alpna Wayal, PhD1 and Jennifer Graves, MD, PhD, MAS2, (1)Octave, Menlo Park, CA, (2)University of California San Diego, San Diego, CA |
2023 | PSY07 | Poster | Psychosocial factors |
Palliative Care Attitudes and Knowledge Among Patients with Neurodemyelinating Diseases |
Aliza B. Ben-Zacharia, PhD, DNP, ANP, FAAN1, Andrea Bartels, MSN, FNP-BC, APRN2, Helen Brugger, MSN, RN2, Jena Malchiodi, JD, RN2, Stephanie Carbone, AD, RN2, Eva Wallace, DNP, FNP-BC, APRN, ACHPN3, Angelo Volandes, MD, MPH4 and Francois Bethoux, MD5, (1)Phillips School of Nursing at Mount Sinai, New York, NY, (2)New Haven Hospital, New Haven, CT, (3)New Haven Hospital, Greenwich, CT, (4)Palliative Care, Co-Founder & President ACP Decisions, Harvard School of Medicine, Boston, MA, (5)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH |
2023 | PSY08 | Poster | Psychosocial factors |
Expanding the Connection between Cognition and Illness Intrusiveness in Multiple Sclerosis: The Contributions of Objective Versus Subjective and Resilience As a Moderator |
Aprille Gangi, HS1, Sarah A Raskin, PhD2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Frederick W Foley, Ph.D.7,8, Lindsay O Neto, MPH9,10 and Elizabeth S Gromisch, PhD, MSCS9,11,12, (1)Trinity College, Hartford, CT, (2)Department of Psychology, Trinity College, Hartford, CT, (3)Neuroscience Program, Trinity College, Hartford, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Holy Name Medical Center, Teaneck, NJ, (8)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (9)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (10)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (11)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (12)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT |
2023 | PSY09 | Poster | Psychosocial factors |
Ethnic Variation in Multiple Sclerosis Progression Lessens When Controlling for Socioeconomic Status |
Delaney Cairns, BS, Medical College of Wisconsin, Milwaukee, WI, Ashley Zeidler, MLIS, Medical College of Wisconsin Libraries, Medical College of Wisconsin, Milwaukee, WI and Ahmed Z Obeidat, MD, PhD, Neurology, Medical College of Wisconsin, Milwaukee, WI |
2023 | PSY10 | Poster | Psychosocial factors |
Are Psychosocial Factors Associated with Physical Therapy Goal Accomplishment in Multiple Sclerosis? |
Kayla Gomes, PT, DPT, NCS1,2, Kaitlin E Riegler, MS3,4, Jennifer Ruiz, DPT5,6, Heather M DelMastro, MS6,7, Aaron P Turner, Ph.D. ABPP (RP)8,9,10, Lindsay O Neto, MPH6,7 and Elizabeth S Gromisch, PhD, MSCS5,6,11, (1)Rehabilitation Care Service, VA Connecticut Healthcare System, Newington, CT, (2)Outpatient Rehabilitation, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (3)Psychology Service, VA Connecticut Healthcare System, West Haven, CT, (4)Department of Psychology, The Pennsylvania State University, University Park, PA, (5)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (6)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (9)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (10)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (11)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT |
2023 | PSY11 | Poster | Psychosocial factors |
Further Validation of the Multiple Sclerosis Resiliency Scale (MSRS) |
Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Heather M DelMastro, MS1,7, Jennifer Ruiz, DPT1,3, Albert C. Lo, MD, PhD1, Thomas P Agresta, MD, MBI8,9 and Frederick W Foley, Ph.D.10,11, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (9)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (10)Holy Name Medical Center, Teaneck, NJ, (11)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY |
2023 | PSY12 | Poster | Psychosocial factors |
Educational Intervention to Improve COVID-19 Vaccination and Booster Rate in Patients with Neuroimmunological Diseases |
Josephe Archie Honorat, MD.PhD., Jonathan Solis Ramirez, MD, Yaacov Anziska, MD and Susanna O’Kula, MD, Neurology Department, SUNY Downstate Health Science University, Brooklyn, NY |
2023 | PSY13 | Poster | Psychosocial factors |
Social Network Size and Mental Health Outcomes in Children and Youth with Neuroinflammatory Disorders |
Paul Y Yoo, PhD, OT, Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, Sonika Kumari, BSc, The Hospital for Sick Children, Toronto, ON, Canada, Samantha Stephens, PhD, Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada and Ann Yeh, M.D., Dept. of Paediatrics, Div. of Neurology, The Hospital for Sick Children, Toronto, ON, Canada |
2023 | PSY14 | Poster | Psychosocial factors |
Association of Mood and Mental Health with Changes in Serum Methylation Markers in Relapsing-Remitting MS: Secondary Analysis of the Waves Trial |
Farnoosh Shemirani, PhD1, Tyler J Titcomb, PhD, RDN1, Solange M Saxby, PhD, RDN1, Patrick Ten Eyck, PhD2, Linda M Rubenstein, PhD3, Linda G Snetselaar, PhD, RDN3 and Terry L Wahls, MD1, (1)Internal Medicine, University of Iowa, Iowa City, IA, (2)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (3)Epidemiology, University of Iowa, Iowa City, IA |
2023 | QOL01 | Poster | Quality of life and outcomes |
Metacognition in Multiple Sclerosis: A Systematic Review of How Patient-Reported Cognitive Health Relates to Cognitive Performance |
Aidan L Peters, MSc, BSc1,2, Kyara Somers, BSc2, Emilie Risdon, BSc3 and Lindsay Berrigan, PhD2, (1)Human Kinetics, University of Ottawa, Ottawa, ON, Canada, (2)Psychology, St. Francis Xavier University, Antigonish, NS, Canada, (3)Health Sciences, St. Francis Xavier University, Antigonish, NS, Canada |
2023 | QOL02 | Poster | Quality of life and outcomes |
Sleep Quality and Related Cognitions in Persons with Multiple Sclerosis: A Pilot Study |
Alaina G Tiani, PhD1, Nicolas Thompson, M.S.2, Alexa Kane, PsyD1, Alicia Roth, PhD, D.BSM3, Michelle Drerup, Psy.D., D.BSM3, Robert A. Bermel, MD4 and Amy B Sullivan, PsyD, ABPP1, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, (3)Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, (4)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH |
2023 | QOL03 | Poster | Quality of life and outcomes |
Acquisition and Use of Assistive Technology from the Perspectives of Older Adults with MS: A Photovoice Study |
Alexandra Jackson, PhD Candidate and Marcia Finlayson, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada |
2023 | QOL04 | Poster | Quality of life and outcomes |
The Impact and Feasibility of a Virtual Dance Program for Patients Living with MS |
Alexandra Pfister, MD1, Meggi Sweeney Smith, MA2, Camryn Lane, BA3, Neel Desai, PhD3, Vanessa Zimmerman, MSN, RN, MSCN4 and Dina Jacobs, MD5, (1)Neurology, University of Pennsylvannia, Philadelphia, PA, (2)New York University, New York City, NY, (3)University of Pennsylvannia, Philadelphia, PA, (4)Neurology, University of Pennsylvania, Philadelphia, PA, (5)Department of Neurology, University of Pennsylvania, Philadelphia, PA |
2023 | QOL05 | Poster | Quality of life and outcomes |
Structural MRI Correlates Are Associated with Fatigue Severity and Persistence in a Large, Real-World Cohort of People with MS |
Alexandra C Simpson, MD, MA, Chen Hu, MS, Kathryn C Fitzgerald, ScD and Bardia Nourbakhsh, MD, MAS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD |
2023 | QOL06 | Poster | Quality of life and outcomes |
Health System Specialty Pharmacist Interventions in Multiple Sclerosis |
Alexis C El-Khouri, PharmD, RPh, Specialty Pharmacy, Trellis Rx, Akron, OH |
2023 | QOL07 | Poster | Quality of life and outcomes |
A Cross-Sectional Study of Telemedicine Use during the COVID-19 Pandemic in People with Multiple Sclerosis |
Anisha M Patel, PhD, MS1, Robert Schuldt, MD1, Denise M Boudreau, PhD1, Nikki Win, PhD1, Bryan R Cobb, PhD1 and Marisa McGinley, DO2, (1)Genentech, Inc., South San Francisco, CA, (2)Cleveland Clinic Foundation, Cleveland, OH |
2023 | QOL08 | Poster | Quality of life and outcomes |
Patient Reported Impact of Multiple Sclerosis on Quality of Life |
Beth Schneider, BA, Research, MyHealthTeam, San Francisco, CA |
2023 | QOL09 | Poster | Quality of life and outcomes |
Mental Health and Quality of Life in Hispanic/Latinx/e and Black/African American Persons with Multiple Sclerosis: Scoping Review and Culturally Relevant Recommendations |
Cristina A.F. Román, Ph.D., Kessler Foundation, West Orange, NJ, Mitzi J. Williams, MD, Joi Life Wellness Group, Atlanta, GA and Sarah C. Pillemer, Ph.D., Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI |
2023 | QOL10 | Poster | Quality of life and outcomes |
Work Productivity and Activity Impairment Among Individuals with Progressive Multiple Sclerosis |
Elham Heidari, PharmD, MSc1,2, Crystal Watson, MS3, Dhanalakshmi Thirumulai, PhD, MPH1, Arie Barlev, PharmD, MS3, Eddie Jones, BA4, Sasha Bogdanovich, MD, PhD1 and Kiren Kresa-Reahl, MD1, (1)Atara Biotherapeutics, Thousand Oaks, CA, (2)College of Pharmacy, The University of Texas at Austin, Austin, TX, (3)Atara Biotherapeutics, South San Francisco, CA, (4)Adelphi Real World, Bollington, Cheshire, United Kingdom |
2023 | QOL11 | Poster | Quality of life and outcomes |
Body Mass Index Trends in Newly Diagnosed Patients with Multiple Sclerosis |
Devon S Conway, MD, MS, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, Karlo Toljan, MD, Neurology, Cleveland Clinic Foundation, Cleveland, OH, Kathleen A Harris, APRN, CNP, Mellen Center, Cleveland Clinic, Cleveland, OH, Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH and Carrie M Hersh, DO, MS, FAAN, Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV |
2023 | QOL12 | Poster | Quality of life and outcomes |
Comparison of Physical Activity between Persons with Multiple Sclerosis with Lower Limb Weakness and Normal Strength |
Heather M DelMastro, MS1,2, Elizabeth S Gromisch, PhD, MSCS1,3,4, Sarah E Frank, PT, DPT1 and Jennifer Ruiz, DPT1,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT |
2023 | QOL13 | Poster | Quality of life and outcomes |
Adoption and Effectiveness of a Toolkit to Promote Academic Success in the Multiple Sclerosis Population |
Erin M Faraclas, PT, DPT, PhD, MSCS, Cameron Watson, PT/s, Andrew Faria, PT/s, Kirsten Sjogren, PT/s and Annalise Lowy, PT/s, School of Physical Therapy, Massachusetts College of Pharmacy and Health Sciences, Worcester, MA |
2023 | QOL14W | Poster | Quality of life and outcomes |
The Next Generation Learning Health System for Multiple Sclerosis (Next-Gen MS): Using Patient Reported Data to Improve MS Care and Outcomes. |
Brant J. Oliver, PhD, MS, MPH, APRN-BC1,2,3, Falguni Mehta, MS, MBA4, Jabeen Ahmad, PhD, MPH4, Christina Caon, MSN, NP5 and Terrie Livingston, PharmD6, (1)The Dartmouth Institute, Hanover, NH, (2)Community of Family and Medicine, Dartmouth Health, Lebanon, NH, (3)Geisel School of Medicine, Dartmouth College, Hanover, NH, (4)Department of Community & Family Medicine, Dartmouth Health, Lebanon, NH, (5)Alliance Management, EMD Serono, Inc., Rockland, MA, (6)EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, MA, Germany |
2023 | QOL15 | Poster | Quality of life and outcomes |
Deep Phenotyping Multiple Sclerosis Patients Using Patient-Reported Outcomes: A Data-Driven Approach |
Farren B.S. Briggs, PhD, ScM1, Douglas D. Gunzler, PhD2, Daniel Ontaneda, MD PhD3, Deborah M Miller, PhD, LISW3, Ryan J Zamora, MS4 and Alessandro De Nadai, PhD4, (1)Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, (2)Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, (3)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (4)McLean Hospital, Harvard Medical School, Belmont, MA |
2023 | QOL16 | Poster | Quality of life and outcomes |
Patient-Reported Outcomes in Treatment-Naive Patients with Early Relapsing-Remitting MS Treated with Ocrelizumab: 4-Year Data from the ENSEMBLE Study |
Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA1,2,3, Carlos Nos, MD4, Amy Perrin Ross, APN, MSN, CNRN, MSCN5, Ludo Vanopdenbosch, MD6, Timothy Vollmer, MD7, Susanne Clinch, PhD8, Inessa Kulyk, MD, MBA9, Thomas Kuenzel, PhD9 and Joep Killestein, MD, PhD10, (1)Department of Neurology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (2)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (3)Brain and Mind Centre, University of Sydney, Sydney, Australia, (4)Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, (5)Loyola University Chicago, Chicago, IL, (6)Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, (7)Department of Neurology, Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus, University of Colorado Denver, Denver, CO, (8)Roche Products Limited, Welwyn Garden City, United Kingdom, (9)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (10)Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands |
2023 | QOL17 | Poster | Quality of life and outcomes |
Mortality in Neuromyelitis Optica Spectrum Disorders – Preliminary Report from a Single Center Study. |
Hari Pradhyumnan, B.S.1, Megan Wurtz, B.S., BSPH1, Stephanie C Picon, MD1, Silvia R Delgado, MD1, Crystal Dixon, MD1, Neeta Garg, MD2, Micheline McCarthy, MD, PhD1, Flavia Nelson, MD1, Melissa Ortega, MD1, Leticia Tornes, MD1 and Kottil Rammohan, MD1, (1)Department of Neurology, Multiple Sclerosis Center, University of Miami, Miami, FL, (2)UCLA, Los Angeles, CA |
2023 | QOL18 | Poster | Quality of life and outcomes |
Concare Continence Care Registry: Gaining Insight into Experiences of the Intermittent Self-Catheterization User |
Jessica A Simmons, DNP, APRN, FNP-C, CWON, DNC1, Diane K Newman, DNP, FAAN, BCB-PMD2, Barbara A Kearns, RGN, BA(Hons), BSc(Hons), DipHE & DipPM1, Daniel A Gordon, M.Sc. Biostatistics1 and Mike A Riemer, MS1, (1)Global Clinical Affairs, Hollister Incorporated, Libertyville, IL, (2)Perelman School of Medicine; Urology in Surgery, University of Pennsylvania, Philladelphia, PA |
2023 | QOL19 | Poster | Quality of life and outcomes |
Implementation of Patient Reported Outcome Measures As Part of Routine Clinical Care – Lessons Learned. |
Kaelianne Newbold, RN, BSN, MSCS, MSCN, Katherine Gwin, RN, BSN, MSCS, MSCN and Nina Bozinov, MD, MS, Neurology, Kootenai Clinic, Coeur d’Alene, ID |
2023 | QOL20 | Poster | Quality of life and outcomes |
Body Mass Index Trends By Disability Level in Multiple Sclerosis Patients |
Kathleen A Harris, APRN, CNP, Mellen Center, Cleveland Clinic, Cleveland, OH, Karlo Toljan, MD, Neurology, Cleveland Clinic Foundation, Cleveland, OH, Carrie M Hersh, DO, MS, FAAN, Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH and Devon S Conway, MD, MS, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH |
2023 | QOL21W | Poster | Quality of life and outcomes |
Assessing the Psychosocial Aspects of MS That Contribute to High Rates of Depression in Individuals with MS |
Kelly E Deragon, PsyD, Health Psychology, Cleveland Clinc Mellen Center, Cleveland, OH and Amy Sullivan, Psy.D., The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH |
2023 | QOL22 | Poster | Quality of life and outcomes |
A Health Needs Assessment Among Lgbtqia+ People Living with MS |
Melissa M Barnhill, MPH, Mission Delivery, Multiple Sclerosis Association of America, Cherry Hill, NJ |
2023 | QOL23 | Poster | Quality of life and outcomes |
Follow the Script: Assessing Access Time and Adherence in Patients with MS |
Nicholas Dangelo, PharmD, CSP, MSCS, Trellis Rx, Atlanta, GA, Courtney Zitterkopf, PharmD, Trellis Rx, Gulfport, MS and Amanda Hickman, PharmD, MPH, MSCS, Central Support Team, Trellis Rx, Atlanta, GA |
2023 | QOL24 | Poster | Quality of life and outcomes |
Using Provider Education to Increase Sleep Apnea Screening Rates in Patients with Multiple Sclerosis (MS): A Quality Improvement Study |
Paige Goulette, DNP, AGPCNP-BC, MSCN1, Beverly Dabney, PhD, RN2, Denise Cooper, DNP, RN, ANP-BC3, Rosemarie Walch, DO4, Jeanie Cote, MD4 and Robert Pace, MD4, (1)Neurology/MS, Memorial Healthcare Institute for Neuroscience, Owosso, MI, (2)Nursing, University of Michigan-Flint, Flint, MI, (3)Flint, MI, (4)Memorial Healthcare Institute for Neuroscience, Owosso, MI |
2023 | QOL25 | Poster | Quality of life and outcomes |
Employment and Patient-Reported Outcomes in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year CASTING and CHORDS Data |
Ralph H.B. Benedict, PhD1, Giancarlo Comi, MD2, Gary Cutter, MS, PhD3, Celia Oreja-Guevara, MD4, Aksel Siva, MD, FEAN5, Bart Van Wijmeersch, MD, PhD6, Bianca Weinstock-Guttman, MD1, Heinz Wiendl, MD, PhD7, Regine Buffels, MD8, Thomas Kuenzel, PhD8, Ashish Pradhan, MD9 and Patrick Vermersch, MD, PhD10, (1)Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, (2)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (3)Department of Biostatistics, UAB School of Public Health, Birmingham, AL, (4)Hospital Clinico San Carlos, Madrid, Spain, (5)Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey, (6)University MS Centre, Pelt, Hasselt University, Hasselt, Belgium, (7)Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, (8)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (9)Genentech, Inc., South San Francisco, CA, (10)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France |
2023 | QOL26 | Poster | Quality of life and outcomes |
A Descriptive Analysis of Intention to Make Changes Following a 5-Week Mindfulness Course for People Living with Multiple Sclerosis. |
Tiffany Malone, MSW, MSCS, Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA |
2023 | QOL27 | Poster | Quality of life and outcomes |
Effects on Quality of Life, Disease Impact and Physical Activity for Men Living with Multiple Sclerosis Participating in a Day Wellness Program |
Brian Hutchinson, PT, MSCS1, Tiffany Malone, MSW, MSCS2, Lacey Sayre, CNA2 and John Schafer, MD3, (1)Multiple Sclerosis Achievement Center, Dignity Health, Sacramento, CA, (2)Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA, (3)Multiple Sclerosis Achievement Center, Citrus Heights, CA |
CMSC Scholar © 2020 All rights Reserved | Proudly Created by Adapting Social